Source link : https://www.newshealth.biz/health-news/nipocalimabs-unique-mechanism-gets-second-chance-in-ra/
The trial proved that nipocalimab reduced IgG antibodies, including anti-citrullinated protein autoantibodies, but the primary endpoint was missed. Medscape Medical News Source link : https://www.medscape.com/viewarticle/nipocalimabs-unique-mechanism-gets-second-chance-rheumatoid-2024a100091h?src=rss Author : Publish date : 2024-05-13 09:24:20 Copyright for syndicated content belongs to the linked Source.
Author : News Health
Publish date : 2024-05-13 09:24:20
Copyright for syndicated content belongs to the linked Source.
in Health